<DOC>
	<DOCNO>NCT02500225</DOCNO>
	<brief_summary>The purpose study investigate effect etomidate sevoflurane use electroconvulsive therapy ( ECT ) duration seizure , hemodynamic response recovery profile .</brief_summary>
	<brief_title>Comparison Effects Etomidate Sevoflurane During Electroconvulsive Therapy</brief_title>
	<detailed_description>Twenty-five patient total 150 ECT treatment prospective , double-blinded , crossover study . Each patient receive either 0.2 mg/kg etomidate ( Group 1 ) 8 % sevoflurane ( Group 2 ) 100 % oxygen 6 L/min fresh gas flow loss consciousness initial electroconvulsive therapy session . In subsequent session , patient receive alternative sevoflurane concentration alternate dos sixth session . Muscle paralysis achieve 1 mg/kg succinylcholine . Motor ( EMG ) electroencephalography seizure duration ( EEG ) , heart rate ( HR ) mean arterial pressure ( MAP ) value , recovery time recorde .</detailed_description>
	<mesh_term>Etomidate</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Study include 25 patient American Society Anesthesiologists ( ASA ) physical status III age 1860 year schedule ECT session general anesthesia Pregnancy Cerebrovascular disease Epilepsy Unstable cardiovascular disease Chronic obstructive pulmonary disease ; Renal hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Etomidate</keyword>
	<keyword>Sevoflurane</keyword>
</DOC>